The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles: spectroscope and molecular modelling identification

References

• Arcamone F, Franceschi G, Penco S, Selva A. 1969. Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Lett 13:1007–1010.
   Google Scholar
• Bast A, Kaiserova H, Den Hartog GJ, Haenen GR, Van Der Vijgh WJ. 2007. Protectors against doxorubicin-induced cardiotoxicity: flavonoids. Cell Biol Toxicol 23:39–47.
   PubMed Web of Science ®Google Scholar
• Berthomieu C, Hienerwadel R. 2001. Iron coordination in photosystem II: interaction between bicarbonate and the QB pocket studied by Fourier transform infrared spectroscopy. Biochemistry 40:4044–4052.
   PubMed Web of Science ®Google Scholar
• Charbonneau D, Beauregard M, Tajmir-Riahi HA. 2009. Structural analysis of human serum albumin complexes with cationic lipids. J Phys Chem B 113:1777–1784.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, 2010. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release 145:17–25.
   PubMed Web of Science ®Google Scholar
• Chi Z, Liu R, Teng Y, Fang X, Gao C. 2010. Binding of oxytetracycline to bovine serum albumin: spectroscopic and molecular modeling investigations. J Agric Food Chem 58:10262–10269.
   PubMed Web of Science ®Google Scholar
• Coker VS, Telling ND, Van Der Laan G, Pattrick RA, Pearce CI, Arenholz E, 2009. Harnessing the extracellular bacterial production of nanoscale cobalt ferrite with exploitable magnetic properties. ACS Nano 3:1922–1928.
   Google Scholar
• Dilnawaz F, Singh A, Mohanty C, Sahoo SK. 2010. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31:3694–3706.
   PubMed Web of Science ®Google Scholar
• Donaldson KL, Goolsby GL, Wahl AF. 1994. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57:847–855.
   PubMed Web of Science ®Google Scholar
• Du B, Han H, Wang Z, Kuang L, Wang L, Yu L, 2010. Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res 8:135–144.
   PubMed Web of Science ®Google Scholar
• Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. 2010. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano 4:5217–5224.
   PubMed Web of Science ®Google Scholar
• He XM, Carter DC. 1992. Atomic structure and chemistry of human serum albumin. Nature 358:209–215.
   PubMed Web of Science ®Google Scholar
• Hoke EM, Maylock CA, Shacter E. 2005. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin. Free Radic Biol Med 39:403–411.
   PubMed Web of Science ®Google Scholar
• Hu YJ, Liu Y, Pi ZB, Qu SS. 2005. Interaction of cromolyn sodium with human serum albumin: a fluorescence quenching study. Bioorg Med Chem 13:6609–6614.
   PubMed Web of Science ®Google Scholar
• Jia X, Chen D, Jiao X, Zhai S 2009. Environmentally-friendly preparation of water-dispersible magnetite nanoparticles. Chem Commun (Camb) 28: 968–970.
   Google Scholar
• Kim YJ, Park CR. 2002. Analysis of problematic complexing behavior of ferric chloride with N,N-dimethylformamide using combined techniques of FT-IR, XPS, and TGA/DTG. Inorg Chem 41:6211–6216.
   PubMed Web of Science ®Google Scholar
• Leung IK, Mani RS, Kay CM. 1987. Fluorescence studies on the Ca2+ and Zn2+ binding properties of the alpha-subunit of bovine brain S-100a protein. FEBS Lett 214:35–40.
   PubMed Web of Science ®Google Scholar
• Li Y, He W, Liu J, Sheng F, Hu Z, Chen X. 2005. Binding of the bioactive component jatrorrhizine to human serum albumin. Biochim Biophys Acta 1722:15–21.
   PubMed Web of Science ®Google Scholar
• Liu R, Qin P, Wang L, Zhao X, Liu Y, Hao X 2010a. Toxic effects of ethanol on bovine serum albumin. J Biochem Mol Toxicol 24:66–71.
   Google Scholar
• Liu R, Sun F, Zhang L, Zong W, Zhao X, Wang L, 2009. Evaluation on the toxicity of nanoAg to bovine serum albumin. Sci Total Environ 407:4184–4188.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu R, Mou Y, Zhou G 2010b. Spectroscopic identification of interactions of formaldehyde with bovine serum albumin. J Biochem Mol Toxicol 25:95–100.
   Google Scholar
• Lo EH, Ooi VE, Fung KP. 2002. Circumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoprotein. Life Sci 72:677–687.
   PubMed Web of Science ®Google Scholar
• Lu JQ, Jin F, Sun TQ, Zhou XW. 2007. Multi-spectroscopic study on interaction of bovine serum albumin with lomefloxacin-copper(II) complex. Int J Biol Macromol 40:299–304.
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Alexiou C, Bergemann C. 2001. Clinical applications of magnetic drug targeting. J Surg Res 95:200–206.
   PubMed Web of Science ®Google Scholar
• Mohapatra S, Pal D, Ghosh SK, Pramanik P. 2007. Design of superparamagnetic iron oxide nanoparticle for purification of recombinant proteins. J Nanosci Nanotechnol 7:3193–3199.
   PubMed Web of Science ®Google Scholar
• Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Souce, M, 2008. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting. Int J Pharm 363:170–176.
   PubMed Web of Science ®Google Scholar
• Papadopoulou A, Green RJ, Frazier RA. 2005. Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study. J Agric Food Chem 53:158–163.
   PubMed Web of Science ®Google Scholar
• Park H, Yang J, Lee J, Haam S, Choi IH, Yoo KH. 2009. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano 3:2919–2926.
   PubMed Web of Science ®Google Scholar
• Sugase K, Dyson HJ, Wright PE. 2007. Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447:1021–1025.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. 2006. Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–1555.
   PubMed Web of Science ®Google Scholar
• Umezawa H, Maeda K, Takeuchi T, Okami Y. 1966. New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 19:200–209.
   PubMed Web of Science ®Google Scholar
• Wang N, Ye L, Yan F, Xu R. 2008. Spectroscopic studies on the interaction of azelnidipine with bovine serum albumin. Int J Pharm 351:55–60.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Zhang HM, Zhang GC, Liu SX, Zhou QH, Fei ZH, Liu ZT. 2007. Studies of the interaction between paraquat and bovine hemoglobin. Int J Biol Macromol 41:243–250.
   PubMed Web of Science ®Google Scholar
• Xiang G, Tong C, Lin H. 2007. Nitroaniline isomers interaction with bovine serum albumin and toxicological implications. J Fluoresc 17:512–521.
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M. 1996. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim Biophys Acta 1295:147–157.
   PubMed Web of Science ®Google Scholar
• Yang Q, Liang J, Han H. 2009. Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J Phys Chem B 113:10454–10458.
   PubMed Web of Science ®Google Scholar
• Yoo MK, Park IY, Kim IY, Park IK, Kwon JS, Jeong HJ, 2008. Superparamagnetic iron oxide nanoparticles coated with mannan for macrophage targeting. J Nanosci Nanotechnol 8:5196–5202.
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu R, Zhao X, Yang B, Gao C, Hao X, Wu Y. 2009. New strategy for the evaluation of CdTe quantum dot toxicity targeted to bovine serum albumin. Sci Total Environ 407:5019–5023.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu R, Chi Z, Teng Y, Qin P. 2010. New insights into the behavior of bovine serum albumin adsorbed onto carbon nanotubes: comprehensive spectroscopic studies. J Phys Chem B 114:5625–5631.
   PubMed Web of Science ®Google Scholar